Experts Weigh in on MBC Subtypes: Hormone Receptor-Positive MBC
Doctors define different types (subtypes) of MBC depending on whether cancer has or does not have three markers—estrogen receptor (ER), progesterone receptor...
Read More PAST ARTICLES
2025
- Getting a Second Opinion About Your MBC
- Side Effects of MBC Treatments: Heart Problems
- Side Effects of MBC Treatments: Infection
- Side Effects of MBC Treatments: Sleep Problems and Mental Health
- Side Effects of MBC Treatments: Hair Loss and Body Image
- Side Effects of MBC Treatments: Lymphedema
- Side Effects of MBC Treatments: Brain Fog and Cognitive Problems
- Side Effects of MBC Treatments: Pain and Neuropathy
- Side Effects of MBC Treatments: Fatigue
2024
- Side Effects of MBC Treatments: Digestive System Side Effects
- Different Types of Imaging Scans: Ultrasound Scans
- Different Types of Imaging Scans: Bone Scans
- Different Types of Imaging Scans: PET/CT Scans
- Different Types of Imaging Scans: MRI
- Update: New Biomarkers Can Now be Used to Select Treatment for MBC
- Managing Symptoms When MBC Spreads to the Bones
- Managing Side Effects of ADCs
- What is “Drug Sequencing”?
- Experts Break Down Important MBC Research from SABCS 2023
2023
- What’s the Difference Between Targeted Therapy and Chemotherapy?
- Leaving a Legacy and Hope: Tissue Donation After Death
- The Latest Research on Inflammatory Breast Cancer
- How is ER Low Used in Clinical Trials?
- Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- What are Clinical Practice Guidelines and How are They Developed?
- ASCO Experts Update Guidance for Sacituzumab Govitecan (Trodelvy®) for HR+, HER2- MBC
- What is Stable Disease and How is it Monitored?
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- Breast Cancer Lung Metastasis: Highlighting the Experts
- Breast Cancer Liver Metastasis: Highlighting the Experts
- Breast Cancer Bone Metastasis: Highlighting the Experts
- Breast Cancer Brain Metastasis: Highlighting the Experts
- Why Do Some People Have an Exceptional Response When Being Treated for MBC?
- Why Does The Same Drug Work Differently In Different People?
- Male MBC Treatment And Clinical Trials
- MBC and NED
2021
- Treatment Strategies for Triple-Positive MBC
- Lobular Metastatic Breast Cancer
- Theragnostics
- Immunotherapy Resistance
- Lymphodepletion in Cancer Immunotherapy
- Local Therapies for Liver Mets
- Side Effects of Radiation Therapy for Brain Mets
- Screening for Breast Cancer Brain Metastases
- What is Next-Generation Sequencing?
2020
2019
SEARCH OUR SITE
for past articles or specific information.